Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / People / Matt Sause
Person

Matt Sause

Tracked across 4 events · 26 articles · First seen Jun 12, 2026 · Last active Jul 14, 2026

Sentiment
30
Attention
6
Events
4
Relationships
2
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (4)
6 60
Tech
Roche Launches AXELIOS 1 Platform
Impact: Matt Sause, CEO of Roche Diagnostics, provided commentary on the disruptive potential of the AXELIOS 1 platform for the sequencing community and personalized healthcare.
Jun 29, 2026 · 7 articles
2 10
Business
Roche launches cobas HDV test
Impact: As CEO of Roche Diagnostics, Matt Sause announced the product launch, underscoring Roche's commitment to liver disease diagnostics.
Jul 14, 2026 · 7 articles
4 50
Regulatory
Roche FDA Approves PTEN Assay
Impact: Matt Sause, CEO of Roche Diagnostics, commented on the significance of the FDA approval for providing new therapeutic options for prostate cancer patients.
Jun 12, 2026 · 6 articles
3 0
Business
Roche Elecsys IGRA TB CE Mark
Impact: As CEO of Roche, Matt Sause announced the CE Mark and highlighted the test's role in advancing TB elimination.
Jul 09, 2026 · 6 articles
Relationships (2)
Roche ↔ Matt Sause
Roche ↔ Matt Sause
ERGEN INTELLIGENCE
Track Matt Sause live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.